Stem cells

As part of the Science|Business Special Report on stem cell research, experts give their opinion on the much debated topic

At the fourth time of asking, the European Medicines Agency is recommending approval of Glybera, opening up a new era in the treatment of rare diseases, and unlocking the wider potential of gene therapy

The UK’s big guns of medical research have united with patients’ group to pre-empt the expected call by some MEPs to end funding of human embryonic stem cell research, when the plan for Horizon 2020 is debated in the European Parliament

Therapies based on human embryonic stem cells should not be granted patents, according to the latest opinion from the Court of Justice of the European Union. If confirmed, this will have a major impact on stem cell research in Europe and on the European life sciences industry as a whole